By continuing to use the site you agree to our Privacy & Cookies policy

Your browser seems to have cookies disabled. For the best experience of this website, please enable cookies in your browser.


Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.


New software predicts CVD risk better than Framingham

General practices will be able to more accurately predict cardiovascular risk following the launch of new computer software, say researchers

QRISK2 uses a new cardiovascular disease equation to estimate an individual’s ten-year CVD risk using analysis of 15 years’ worth of real primary care data. The software is the result of a not-for-profit partnership between the University of Nottingham and primary care system supplier EMIS.

Unlike the traditional Framingham risk score, QRISK2 takes into account the higher risk of developing CVD to patients from deprived areas and from certain ethnic groups. It also considers other risk factors, including whether the patient already suffers from a pre-existing condition such as diabetes.

Professor Julia Hippisley-Cox, from the University of Nottingham’s division of primary care, said: ‘We believe this formula has the potential to save many thousands of lives, by helping clinicians to more accurately predict those at risk of developing cardiovascular disease – the nation’s biggest killer.’

The QRISK2 software will be incorporated into existing EMIS clinical records systems – used by 56% of GP surgeries in the UK. It will support Government plans for a£250 million national cardiovascular screening programme, which will offer checks to everyone between the ages of 40 and 70.

Have your say

You must sign in to make a comment.

Related Jobs

Sign in to see the latest jobs relevant to you!